Assessment of the relative success of sporozoite inoculations in individuals exposed to moderate seasonal transmission
-
Published:2009-07-15
Issue:1
Volume:8
Page:
-
ISSN:1475-2875
-
Container-title:Malaria Journal
-
language:en
-
Short-container-title:Malar J
Author:
Tall Adama,Sokhna Cheikh,Perraut Ronald,Fontenille Didier,Marrama Laurence,Ly Alioune B,Sarr Fatoumata D,Toure Aïssatou,Trape Jean-François,Spiegel André,Rogier Christophe,Druilhe Pierre
Abstract
Abstract
Background
The time necessary for malaria parasite to re-appear in the blood following treatment (re-infection time) is an indirect method for evaluating the immune defences operating against pre-erythrocytic and early erythrocytic malaria stages. Few longitudinal data are available in populations in whom malaria transmission level had also been measured.
Methods
One hundred and ten individuals from the village of Ndiop (Senegal), aged between one and 72 years, were cured of malaria by quinine (25 mg/day oral Quinimax™ in three equal daily doses, for seven days). Thereafter, thick blood films were examined to detect the reappearance of Plasmodium falciparum every week, for 11 weeks after treatment. Malaria transmission was simultaneously measured weekly by night collection of biting mosquitoes.
Results
Malaria transmission was on average 15.3 infective bites per person during the 77 days follow up. The median reappearance time for the whole study population was 46.8 days, whereas individuals would have received an average one infective bite every 5 days. At the end of the follow-up, after 77 days, 103 of the 110 individuals (93.6%; CI 95% [89.0–98.2]) had been re-infected with P. falciparum. The median reappearance time ('re-positivation') was longer in subjects with patent parasitaemia at enrolment than in parasitologically-negative individuals (58 days vs. 45.9; p = 0.03) and in adults > 30 years than in younger subjects (58.6 days vs. 42.7; p = 0.0002). In a multivariate Cox PH model controlling for the sickle cell trait, G6PD deficiency and the type of habitat, the presence of parasitaemia at enrolment and age ≥ 30 years were independently predictive of a reduced risk of re-infection (PH = 0.5 [95% CI: 0.3–0.9] and 0.4; [95% CI: 0.2–0.6] respectively).
Conclusion
Results indicate the existence of a substantial resistance to sporozoites inoculations, but which was ultimately overcome in almost every individual after 2 1/2 months of natural challenges. Such a study design and the results obtained suggest that, despite a small sample size, this approach can contribute to assess the impact of intervention methods, such as the efficacy vector-control measures or of malaria pre-erythrocytic stages vaccines.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Parasitology
Reference31 articles.
1. Rogier C, Tall A, Diagne N, Fontenille D, Spiegel A, Trape JF: Plasmodium falciparum clinical malaria: lessons from longitudinal studies in Senegal. Parassitologia. 1999, 41: 255-259. 2. Druilhe P, Renia L, Fidock D: Immunity to liver stages. Malaria: parasite biology, pathogenesis and protection. Edited by: Sherman IW. 1998, Washington DC: ASM Press, 513-543. 3. Bottius E, BenMohamed L, Brahimi K, Gras H, Lepers JP, Raharimalala L, Aikawa M, Meis J, Slierendregt B, Tartar A: A novel Plasmodium falciparum sporozoite and liver stage antigen (SALSA) defines major B, T helper, and CTL epitopes. J Immunol. 1996, 156: 2874-2884. 4. Druilhe P, Pradier O, Marc JP, Miltgen F, Mazier D, Parent G: Levels of antibodies to Plasmodium falciparum sporozoite surface antigens reflect malaria transmission rates and are persistent in the absence of reinfection. Infect Immun. 1986, 53: 393-397. 5. Fidock DA, Bottius E, Brahimi K, Moelans II, Aikawa M, Konings RN, Certa U, Olafsson P, Kaidoh T, Asavanich A: Cloning and characterization of a novel Plasmodium falciparum sporozoite surface antigen, STARP. Mol Biochem Parasitol. 1994, 64: 219-232. 10.1016/0166-6851(94)00012-3.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|